Literature DB >> 25425568

High-throughput kinetic screening of hybridomas to identify high-affinity antibodies using bio-layer interferometry.

Latesh Lad1, Sheila Clancy2, Maria Kovalenko2, Chian Liu2, Terence Hui3, Victoria Smith2, Nikos Pagratis2.   

Abstract

Kinetic analysis of antibodies is crucial in both clone selection and characterization. Historically, antibodies in supernatants from hybridomas are selected based on a solid-phase enzyme-linked immunosorbent assay (ELISA) in which the antigen is immobilized on the assay plate. ELISA selects clones based on a combination of antibody concentration in the supernatant and affinity. The antibody concentration in the supernatant can vary significantly and is typically unknown. Using the ELISA method, clones that express high levels of a low-affinity antibody can give an equivalent signal as clones that express low levels of a high-affinity antibody. As a consequence, using the ELISA method, superior clones can be overshadowed by inferior clones. In this study, we have applied Bio-Layer Interferometry to screen hybridoma clones based on disassociation rates using the OctetRED 384 platform. Using the OctetRED platform, we were able to screen 2000 clones within 24 hours and select clones containing high-affinity antibodies for further expansion and subsequent characterization. Using this method, we were able to identify several clones producing high-affinity antibodies that were missed by ELISA.
© 2014 Society for Laboratory Automation and Screening.

Keywords:  bio-layer interferometry; high-throughput screening; label-free

Mesh:

Year:  2014        PMID: 25425568     DOI: 10.1177/1087057114560123

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  14 in total

1.  Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms.

Authors:  Danlin Yang; Ajit Singh; Helen Wu; Rachel Kroe-Barrett
Journal:  J Vis Exp       Date:  2017-04-17       Impact factor: 1.355

Review 2.  Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development.

Authors:  Rejane L Petersen
Journal:  Biosensors (Basel)       Date:  2017-10-31

3.  Targeted Delivery to Tumor-associated Pericytes via an Affibody with High Affinity for PDGFRβ Enhances the in vivo Antitumor Effects of Human TRAIL.

Authors:  Ze Tao; Hao Yang; Qiuxiao Shi; Qing Fan; Lin Wan; Xiaofeng Lu
Journal:  Theranostics       Date:  2017-06-01       Impact factor: 11.556

Review 4.  Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.

Authors:  Hilal Ahmed Parray; Shivangi Shukla; Sweety Samal; Tripti Shrivastava; Shubbir Ahmed; Chandresh Sharma; Rajesh Kumar
Journal:  Int Immunopharmacol       Date:  2020-05-27       Impact factor: 4.932

5.  BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody.

Authors:  Jong Rip Choi; Min Jung Kim; Nara Tae; Tae Min Wi; Se-Ho Kim; Eung Suk Lee; Dae Hee Kim
Journal:  Viruses       Date:  2020-06-25       Impact factor: 5.048

6.  Rational antibody design for undruggable targets using kinetically controlled biomolecular probes.

Authors:  Carolina L Trkulja; Oscar Jungholm; Max Davidson; Kent Jardemark; Monica M Marcus; Jessica Hägglund; Anders Karlsson; Roger Karlsson; Joseph Bruton; Niklas Ivarsson; Sreesha P Srinivasa; Alexandra Cavallin; Peder Svensson; Gavin D M Jeffries; Maria-Nefeli Christakopoulou; Anna Reymer; Anaswara Ashok; Gabriella Willman; Daniela Papadia; Emma Johnsson; Owe Orwar
Journal:  Sci Adv       Date:  2021-04-16       Impact factor: 14.136

7.  An experimental approach probing the conformational transitions and energy landscape of antibodies: a glimmer of hope for reviving lost therapeutic candidates using ionic liquid.

Authors:  Talia A Shmool; Laura K Martin; Liem Bui-Le; Ignacio Moya-Ramirez; Pavlos Kotidis; Richard P Matthews; Gerhard A Venter; Cleo Kontoravdi; Karen M Polizzi; Jason P Hallett
Journal:  Chem Sci       Date:  2021-06-22       Impact factor: 9.825

8.  Continuous microfluidic assortment of interactive ligands (CMAIL).

Authors:  Yi-Hsing Hsiao; Chao-Yang Huang; Chih-Yung Hu; Yen-Yu Wu; Chung-Hsiun Wu; Chia-Hsien Hsu; Chihchen Chen
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

9.  Understanding ForteBio's Sensors for High-Throughput Kinetic and Epitope Screening for Purified Antibodies and Yeast Culture Supernatant.

Authors:  Yao Yu; Scott Mitchell; Heather Lynaugh; Michael Brown; R Paul Nobrega; Xiaoyong Zhi; Tingwan Sun; Isabelle Caffry; Yuan Cao; Rong Yang; Irina Burnina; Yingda Xu; Patricia Estep
Journal:  J Biomol Screen       Date:  2015-10-06

10.  Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection.

Authors:  Adva Mechaly; Einat B Vitner; Yinon Levy; David Gur; Moria Barlev-Gross; Assa Sittner; Michal Koren; Haim Levy; Emanuelle Mamroud; Morly Fisher
Journal:  Pathogens       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.